US FDA approvals bounce back in 2023, sparking hopes of a biotech recovery - ET HealthWorld | Pharma
Bengaluru: The US Food and Drug Administration approved nearly 50 per cent …
Bengaluru: The US Food and Drug Administration approved nearly 50 per cent …
New Delhi: The US health regulator on Tuesday declined to grant traditional…
Mumbai: Lupine Limited announced that it has received approval from the Uni…
New Delhi: The US Food and Drug Administration has placed a clinical hold …
Mumbai: Alembic Pharmaceuticals Limited announced that it has received US F…
Mumbai: Alembic Pharmaceuticals Limited announced that it has received US F…
Mumbai: Alembic Pharmaceuticals Limited announced that it has received US F…